Table 1.
Disease name | Vaccine available | Highest level of evidence for neurological manifestations | Affects CNS, PNS, or both | Most common systemic presentation | Most common neurological presentation | Pathogen found in CSF | Neuroimaging findings | Management |
---|---|---|---|---|---|---|---|---|
Chikungunya | No | Case series, case-control study, cross-sectional study (with systematic review covering all of these) | Majority CNS, 25% PNS | Fever, malaise, arthralgias | Encephalopathy, myelitis | IgM found in CSF | Punctate foci of T2 signal in periventricular, limbic areas | Supportive care |
Cholera | Yes | Retrospective analysis, case series | CNS | Diarrhea, dehydration | Meningitis, abscess | Yes | Uncertain | Aggressive volume repletion plus antibiotic therapy |
COVID-19 | No | Case series, case reports | CNS, PNS | Fever, chills cough, shortness of breath, fatigue, myalgias, headache, loss of taste or smell, nausea, vomiting, diarrhea | Encephalitis, headache, Guillain-Barre syndrome, myelitis | Uncertain | Uncertain | Supportive care |
Crimean-Congo hemorrhagic fever | No | Prospective cohort study, case series | CNS | Fever, myalgias, GI disturbance, hemorrhage | Headache, dizziness, encephalopathy, ICH | Uncertain, viral RNA found in brain tissue in animal models | Normal findings, or diffuse hemorrhage | Supportive care |
Ebola virus disease | Yes | Large prospective cohort study | Majority CNS | High fevers, fatigue, myalgias, conjunctival injection, chest pain, arthralgias. | Headache, diffuse weakness, encephalopathy | Yes | Punctate T2 and DWI lesions in corpus callosum and cerebral white matter* | Supportive care |
Hendra virus infection | No human vaccine available | Case series | CNS | Fever, respiratory symptoms | Headache, meningitis, encephalitis, seizures | Antibodies found in CSF; likely viral inclusion bodies on autopsy | Early isolated cortical signal, later deep white matter involvement | Supportive care |
Influenza | Yes | Large prospective cohort study | CNS and PNS | Fever, headache, myalgia, malaise | Headache, seizure, encephalopathy | Rarely | Increased DWI signal in cortex and adjacent white matter | Supportive care |
Lassa fever | No | Retrospective case series | CNS | 80% asymptomatic; otherwise malaise, fever, bleeding | Sensorineural hearing loss, encephalopathy | Yes | Uncertain | Supportive care |
Marburg virus disease | No | Case series, case studies | CNS | High fever, headache, malaise, myalgias, diarrhea, hemorrhage | Encephalitis, headache, hemorrhage | Antibodies in CSF | Uncertain | Supportive care |
MERS-CoV | No | Retrospective case series | CNS and PNS | Respiratory disease with fever, cough, shortness of breath | Headache, encephalopathy, seizures, focal motor deficits, weakness, paresthesias, ophthalmoplegia and ataxia | No | Patchy diffusion restriction and T2 hyperintensity | Supportive care |
Monkeypox | No, although some cross-reactivity from smallpox vaccine | Two case reports | CNS | Asymptomatic, or fevers and rash | Encephalitis | Uncertain | Uncertain | Supportive care |
Neisseria meningitidis meningitis | Yes | Large retrospective cohorts and reviews | CNS | Fever, nausea, vomiting, myalgias, petechial rash, sepsis | Headache, neck stiffness, altered mental status | Yes | Non-specific T2 abnormalities | Antibiotic therapy plus prophylaxis for close contacts |
Nipah virus infection | No | Case series | CNS | Viral pneumonia, fever | Fulminant encephalitis with headache and meningismus | Antibodies in CSF | Many asymmetric, small lesions in subcortical white matter | Supportive care |
Plague | Yes, although no longer available in U.S. | Retrospective analysis, case series | CNS | Buboes, high fever, shock | Meningitis | Yes | Uncertain | Antibiotic therapy plus prophylaxis for face-to-face exposures |
Rift valley fever | No, but an inactivated vaccine has been trialed in humans | Prospective study, Case-control study, cross-sectional study | CNS | Mild flu-like illness, fever, joint paint pain, muscle ache | Encephalopathy, meningoencephalitis | No, but found in animal studies | Bilateral asymmetrical cortical hyperintense areas* | Supportive care |
SARS | No | Case studies, case reports | CNS | Fever, cough, shortness of breath, diarrhea | Headache, encephalitis | Yes | Uncertain | Supportive care |
Smallpox | Yes, but not commonly available | Case-series, retrospective analysis (for vaccine related complications) | CNS | Fevers, malaise, vesicular/pustular rash | Encephalopathy, headaches | Uncertain | Uncertain | Supportive care; tecovirimat FDA-approved but sparsely tested |
Tularemia | No | Case reports | CNS and PNS | Fever, regional tender lymphadenopathy, conjunctivitis, pharyngitis, pneumonia | Overall rare, though meningitis, ataxia, polycraniitis, and Guillain Barre syndrome have been reported | Yes | Meningeal enhancement, scattered T2-intense lesions. Can present with abscess. | Antibiotic therapy |
Yellow fever | Yes | Case-series, retrospective study | CNS | Fevers, minority with hemorrhagic fever | Encephalopathy, seizures | Yes | Petechiae, perivascular hemorrhages and edema | Supportive care |
Zika virus disease | No | Large retrospective cohorts | CNS and PNS | Fever, arthralgias, headache, rash | Guillain-Barre syndrome, fetal microcephaly | Yes | Typical GBS findings; infants: subcortical calcifications and microcephaly | Supportive care |
Characterized only in individual case report.